Amy E. Campbell

2.0k total citations
28 papers, 1.1k citations indexed

About

Amy E. Campbell is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Amy E. Campbell has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Hematology. Recurrent topics in Amy E. Campbell's work include RNA Research and Splicing (11 papers), Muscle Physiology and Disorders (9 papers) and RNA modifications and cancer (9 papers). Amy E. Campbell is often cited by papers focused on RNA Research and Splicing (11 papers), Muscle Physiology and Disorders (9 papers) and RNA modifications and cancer (9 papers). Amy E. Campbell collaborates with scholars based in United States, Netherlands and Australia. Amy E. Campbell's co-authors include Stephen J. Tapscott, Gerd A. Blobel, Sean Shadle, Silvère M. van der Maarel, Ross C. Hardison, Joel P. Mackay, Rabi Tawil, Zhong Deng, Paul M. Lieberman and Stephan Kadauke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Amy E. Campbell

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy E. Campbell United States 17 944 178 128 122 96 28 1.1k
Saiphone Webb United States 12 444 0.5× 98 0.6× 67 0.5× 16 0.1× 90 0.9× 16 703
Jeff Bailey United States 15 414 0.4× 127 0.7× 78 0.6× 8 0.1× 94 1.0× 26 636
Xonia Carvajal‐Vergara Spain 11 504 0.5× 281 1.6× 49 0.4× 21 0.2× 184 1.9× 18 736
Chang S. Lau United States 6 368 0.4× 98 0.6× 53 0.4× 12 0.1× 41 0.4× 7 572
Gwendolyn M. Mahon United States 16 408 0.4× 102 0.6× 67 0.5× 9 0.1× 91 0.9× 21 786
Sean F. Landrette United States 12 441 0.5× 191 1.1× 62 0.5× 10 0.1× 108 1.1× 18 663
Aaron D. DeWard United States 12 351 0.4× 50 0.3× 29 0.2× 25 0.2× 121 1.3× 14 697
Tetsuo Kojima Japan 11 326 0.3× 155 0.9× 56 0.4× 8 0.1× 117 1.2× 28 818
Weili Wang China 12 449 0.5× 154 0.9× 45 0.4× 9 0.1× 53 0.6× 25 651
Ariane I. de Agostini United States 11 339 0.4× 237 1.3× 43 0.3× 29 0.2× 12 0.1× 13 706

Countries citing papers authored by Amy E. Campbell

Since Specialization
Citations

This map shows the geographic impact of Amy E. Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Campbell more than expected).

Fields of papers citing papers by Amy E. Campbell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Campbell. The network helps show where Amy E. Campbell may publish in the future.

Co-authorship network of co-authors of Amy E. Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Campbell. A scholar is included among the top collaborators of Amy E. Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Campbell. Amy E. Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Rui, Alexey Shuvalov, Amy E. Campbell, et al.. (2025). Systematic analysis of nonsense variants uncovers peptide release rate as a novel modifier of nonsense-mediated mRNA decay. Cell Genomics. 5(7). 100882–100882. 1 indexed citations
2.
Campbell, Amy E., et al.. (2024). A system of reporters for comparative investigation of EJC-independent and EJC-enhanced nonsense-mediated mRNA decay. Nucleic Acids Research. 52(6). e34–e34. 5 indexed citations
3.
Hamm, Danielle C., Sean Bennett, Chao-Jen Wong, et al.. (2023). The transcription factor DUX4 orchestrates translational reprogramming by broadly suppressing translation efficiency and promoting expression of DUX4-induced mRNAs. PLoS Biology. 21(9). e3002317–e3002317. 5 indexed citations
4.
Campbell, Amy E., Jamshid Arjomand, Oliver D. King, Rabi Tawil, & Sujatha Jagannathan. (2023). A Targeted Approach for Evaluating DUX4-Regulated Proteins as Potential Serum Biomarkers for Facioscapulohumeral Muscular Dystrophy Using Immunoassay Proteomics. Journal of Neuromuscular Diseases. 10(6). 1031–1040. 2 indexed citations
5.
Campbell, Amy E., Michael C. Dyle, Tyler Matheny, et al.. (2023). Compromised nonsense-mediated RNA decay results in truncated RNA-binding protein production upon DUX4 expression. Cell Reports. 42(6). 112642–112642. 16 indexed citations
6.
Leung, Doris G., Jamshid Arjomand, Julie Dumonceaux, et al.. (2022). Meeting report: The 2022 FSHD International Research Congress. Neuromuscular Disorders. 33(2). 196–198.
7.
Shadle, Sean, Sean Bennett, Chao-Jen Wong, et al.. (2019). DUX4-induced bidirectional HSATII satellite repeat transcripts form intranuclear double-stranded RNA foci in human cell models of FSHD. Human Molecular Genetics. 28(23). 3997–4011. 27 indexed citations
8.
Galasinski, Scott, Amy E. Campbell, Marvin J. Meyers, et al.. (2019). Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy. Journal of Pharmacology and Experimental Therapeutics. 370(2). 219–230. 61 indexed citations
9.
Chew, Guo-Liang, Amy E. Campbell, Emma De Neef, et al.. (2019). DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade. Developmental Cell. 50(5). 658–671.e7. 77 indexed citations
10.
Campbell, Amy E., Sean Shadle, Sujatha Jagannathan, et al.. (2018). NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins. eLife. 7. 46 indexed citations
11.
Wang, Leo H., Seth D. Friedman, Dennis Shaw, et al.. (2018). MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD. Human Molecular Genetics. 28(3). 476–486. 84 indexed citations
12.
Wai, Dorothy C.C., Amy E. Campbell, Lorna Wilkinson‐White, et al.. (2018). The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators. Journal of Biological Chemistry. 293(19). 7160–7175. 44 indexed citations
13.
Campbell, Amy E., Matthew Yates, Jun Zhong, et al.. (2017). BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells. Skeletal Muscle. 7(1). 16–16. 51 indexed citations
14.
Shadle, Sean, Jun Zhong, Amy E. Campbell, et al.. (2017). DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy. PLoS Genetics. 13(3). e1006658–e1006658. 73 indexed citations
15.
Campbell, Amy E., Lorna Wilkinson‐White, Joel P. Mackay, Jacqueline M. Matthews, & Gerd A. Blobel. (2013). Analysis of disease-causing GATA1 mutations in murine gene complementation systems. Blood. 121(26). 5218–5227. 39 indexed citations
16.
Lamonica, Janine M., Wulan Deng, Stephan Kadauke, et al.. (2011). Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes. Proceedings of the National Academy of Sciences. 108(22). E159–68. 181 indexed citations
17.
Campbell, Amy E., et al.. (2010). Molecular architecture of CTCFL. Biochemical and Biophysical Research Communications. 396(3). 648–650. 12 indexed citations
18.
Deng, Zhong, Amy E. Campbell, & Paul M. Lieberman. (2010). TERRA, CpG methylation, and telomere heterochromatin: Lessons from ICF syndrome cells. Cell Cycle. 9(1). 69–74. 75 indexed citations
19.
Campbell, Amy E., et al.. (1997). Altered expression of mucins throughout the colon in ulcerative colitis.. Gut. 40(2). 234–240. 35 indexed citations
20.
Campbell, Amy E., et al.. (1958). The waxes and lipoids of resistant houseflies and mosquitoes.. PubMed. 12. 547–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saiphone Webb Breakdown of academic impact, for papers by Jeff Bailey Breakdown of academic impact, for papers by Xonia Carvajal‐Vergara Breakdown of academic impact, for papers by Chang S. Lau Breakdown of academic impact, for papers by Gwendolyn M. Mahon Breakdown of academic impact, for papers by Sean F. Landrette Breakdown of academic impact, for papers by Aaron D. DeWard Breakdown of academic impact, for papers by Tetsuo Kojima Breakdown of academic impact, for papers by Weili Wang Breakdown of academic impact, for papers by Ariane I. de Agostini
Rankless by CCL
2026